These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2446811)

  • 21. Low-titer antibodies reactive with HTLV-I gag p19 in patients with chronic myeloneuropathy.
    Kawanishi T; Akiguchi I; Fujita M; Kameyama M; Hatanaka M
    Ann Neurol; 1989 Oct; 26(4):515-22. PubMed ID: 2510585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
    J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
    Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quantification of serum antibodies against liver cell membrane (anti-LM) in patients with liver diseases by ELISA--fixation of the antibody on a microplate using protein A and the significance of anti-LM detection].
    Tsuji T
    Rinsho Byori; 1983 Jun; 31(6):641-5. PubMed ID: 6361333
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and neuritogenic activity of the peptides related to P2 protein.
    Suzuki M; Kitamura K; Uyemura K; Ogawa Y; Nozaki S; Muramatsu I
    Prog Clin Biol Res; 1984; 146():487-92. PubMed ID: 6201917
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein.
    Mshana RN; Harboe M; Stoner GL; Hughes RA; Kadlubowski M; Belehu A
    Int J Lepr Other Mycobact Dis; 1983 Mar; 51(1):33-40. PubMed ID: 6190769
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
    Kusunoki S; Chiba A; Kon K; Ando S; Arisawa K; Tate A; Kanazawa I
    Ann Neurol; 1994 May; 35(5):570-6. PubMed ID: 8179303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathological comparative studies on experimental allergic neuritis (EAN) induced in rabbits by P2 protein-ganglioside complexes.
    Takeda S; Ikuta F; Nagai Y
    Jpn J Exp Med; 1980 Dec; 50(6):453-62. PubMed ID: 6168787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of P2 protein in swine flu vaccines.
    Brostoff SW; White TM
    JAMA; 1982 Jan 22-29; 247(4):495. PubMed ID: 6172604
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody.
    Berger JR; Rosenfeld WE; Sheremata WA; Lian EC; Ayyar DR; Melo J; Kloss K
    Neurology; 1983 Sep; 33(9):1224-6. PubMed ID: 6412159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cardiolipin antibodies in neurological diseases.
    Colaco CB; Scadding G; Newsom-Davis J
    Lancet; 1984 Jan; 1(8369):164. PubMed ID: 6140468
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-P2 protein antibodies in patients with polyradiculoneuropathy].
    Ito H; Saito T; Kowa H
    Rinsho Shinkeigaku; 1987 Aug; 27(8):976-82. PubMed ID: 2446811
    [No Abstract]   [Full Text] [Related]  

  • 37. Highly sensitive-beta-D-galactosidase-linked immunosorbent assay for anti-myelin basic protein antibody.
    Akiyama K
    Jpn J Exp Med; 1983 Aug; 53(4):181-5. PubMed ID: 6198541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myelin basic protein, anti-sulfated glucuronyl paragloboside (SGPG) antibody and anti-P0 antibody].
    Ohta M; Ohta K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():641-4. PubMed ID: 20942152
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the antibody response using the ENC-HEM Sevac kit. Further experience].
    Jílek D; Král V; Haasová L
    Cas Lek Cesk; 1986 Jul; 125(28):869-70. PubMed ID: 2425972
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system.
    Sellebjerg F; Madsen HO; Frederiksen JL; Ryder LP; Svejgaard A
    Ann Neurol; 1995 Dec; 38(6):943-50. PubMed ID: 8526468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.